CryoLife (CRY) Tops Q3 EPS by 8c, Boosts FY Guidance
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
CryoLife (NYSE: CRY) reported Q3 EPS of $0.13, $0.08 better than the analyst estimate of $0.05. Revenue for the quarter came in at $45.3 million versus the consensus estimate of $44.9 million.
CryoLife sees FY2016 EPS of $0.43-$0.45, versus prior guidance of $0.32-$0.34. CryoLife sees FY2016 revenue of $181-182.5 million, versus prior guidance of $180-182 million.
For earnings history and earnings-related data on CryoLife (CRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vera Bradley (VRA) Tops Q3 EPS by 1c; Offers Light Q4 Outlook; Enters New Licensing Agreements
- Dave & Buster's Entertainment (PLAY) Tops Q3 EPS by 11c, Raises FY Revenue Guidance
- SecureWorks Corp. (SCWX) Tops Q3 EPS by 6c; Guides Q4, FY17